How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

这项研究由来自美国伊利诺伊大学厄巴纳-香槟分校、斯坦福大学、英伟达和麻省理工学院的研究团队联合完成，以预印本形式于2026年4月28日发布在arXiv平台，论文编号为arXiv:2604.25917v1。研究背景：一个AI打天下，为什么越来越吃力？先 ...

Arcjet thinks it has the answer. The company this week introduced Guards, a service designed to enforce security inside AI ...

According to Rogers, the computer science faculty use Gradescope’s Measure Of Software Similarity (MOSS) tool to identify ...

Home » Security Bloggers Network » Shai-Hulud Strikes SAP: Supply Chain Worm Weaponized Claude Code to Compromise the CAP Framework The post Shai-Hulud Strikes SAP: Supply Chain Worm Weaponized Claude ...